Assignee
ATOSSA THERAPEUTICS INC
US·9 granted patents·18 pending applications·31 citations·filing 2018–2025
Top patents by PatentIndex Score
27 records- 0196US12275684B2Methods for making and using endoxifenATOSSA THERAPEUTICS INC·Filed 2024·Granted Apr 15, 2025·2 cites·98 claims
- 0296US12071391B2Methods for making and using endoxifenATOSSA THERAPEUTICS INC·Filed 2023·Granted Aug 27, 2024·4 cites·44 claims
- 0396US11680036B1Methods for making and using endoxifenATOSSA THERAPEUTICS INC·Filed 2022·Granted Jun 20, 2023·6 cites·22 claims
- 0496US11572334B2Methods for making and using endoxifenATOSSA THERAPEUTICS INC·Filed 2022·Granted Feb 7, 2023·8 cites·22 claims
- 0595US12281056B2Methods for making and using endoxifenATOSSA THERAPEUTICS INC·Filed 2023·Granted Apr 22, 2025·1 cites·58 claims
- 0695US11261151B2Methods for making and using endoxifenATOSSA THERAPEUTICS INC·Filed 2018·Granted Mar 1, 2022·9 cites·21 claims
- 0793US2026028308A1Methods for making and using endoxifenATOSSA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0883US12479790B2Methods for making and using endoxifenATOSSA THERAPEUTICS INC·Filed 2025·Granted Nov 25, 2025·0 cites·100 claims
- 0981US12201591B2Sustained release compositions of endoxifenATOSSA THERAPEUTICS INC·Filed 2020·Granted Jan 21, 2025·1 cites·31 claims
- 1078US2025282710A1Methods for making and using endoxifenATOSSA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1173US2025255838A1Sustained release compositions of endoxifenATOSSA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1272US2025241876A1Anti-tumor compounds and methods of use thereof and synthesis thereofATOSSA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1368US2024148675A1Topical compositions and methods for treatmentATOSSA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1466US2024274234A1Remote detection of pathogensATOSSA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1565US2025281414A1High dose endoxifen formulations and methods of useATOSSA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1664US2024261392A1Compositions and methods to increase coronavirus immune responseATOSSA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1763US12576103B2Heparin and N-acetylcysteine for the treatment of lung injuryATOSSA THERAPEUTICS INC·Filed 2021·Granted Mar 17, 2026·0 cites·16 claims
- 1863US2026034166A1Heparin compositions for treatment of lung damage and methods of use thereofATOSSA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1958US2024156752A1Endoxifen for treatment of ovarian cancerATOSSA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2058US2023364221A1Viral vaccine compositions for inoculating a subject against a coronavirus, an influenza virus, or bothATOSSA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2158US2025041245A1Endoxifen for treatment of cancersATOSSA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2255US2020215006A1Topical compositions and methods for treatmentATOSSA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2353US2025066286A1Compositions of (z)-endoxifen and methods of enrichment thereofATOSSA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2452US2021060052A1In situ methods of inducing of immune responseATOSSA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2551US2021000920A1Intraductal methods of treatment of breast disordersATOSSA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2649US2023059521A1Methods of treating or preventing a viral infection using bacteriophagesATOSSA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2745US2020268690A1Topical compositionsATOSSA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ATOSSA THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →